About Insitro
insitro is a machine learning-driven drug discovery and development company that uses data generation at scale and ML to transform how drugs are discovered and delivered to patients. Its platform integrates cellular and human clinical data to identify therapeutic insights across diseases including metabolism, oncology, and neuroscience. The company partners with major pharmaceutical firms such as Gilead and Bristol Myers Squibb.
Company details
Funding
Total raised
$643M
Last stage
Growth
Investors
Founders
Daphne Koller
AI/ML pioneer and former Stanford professor; co-founder and former co-CEO of Coursera; former Chief Computing Officer at Calico (Alphabet). Founded insitro in 2018 to apply machine learning to drug discovery.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.